Surf Bio Announces $16 Million Series Seed Financing
– Proceeds to Advance Breakthrough Drug Stabilization Technology Enabling Thermostable and Concentrated Formulation of Biologics –– Financing Co-Led by Breakout Ventures and the Perceptive Xontogeny Venture Fund –PALO ALTO, Calif.--(BUSINESS WIRE)--Surf Bio, Inc., a biopharmaceutical company commercializing a novel...
Source: pharmiweb.com